To test whether α2M*/CS-GRP78 signaling regulates AKT activation to modulate histone acetylation, we treated the various cancer cell lines with C38 Mab and then stimulated with α2M* and acetate either alone or in combination. This evidence concerns the gene A2M and cancer.